Market LIVE
Published markets; coverage varies by country
Product profile · United States

SUNLENCA

 ·  Patent Litigation & Settlement History ↓

IngredientLENACAPAVIR SODIUM
Application typeNDA
Application215973
Product001
Dosage formSOLUTION
RouteSUBCUTANEOUS
StrengthEQ 463.5MG BASE/1.5ML (EQ 309MG BASE/ML)
Approval date2022-12-22
Marketing statusPrescription
Status event—
ApplicantGILEAD SCIENCES INC
Product source

Current GenericRadar decision

Year2037
SelectionDEEP_REVIEW
ReviewFINAL
Anchor typeTRUE_DS_PATENT
Anchor date2037-08-17
Patent anchor2037-08-17
Exclusivity anchor2027-12-22
Protection date2038-08-16
First Final ANDA—
Status event—

ANCHOR_WITH_TAIL; US:NDA:215973:001; exact Final ANDA not verified; not proof of generic absence

Patent estate

PatentEffective dateOfficial listingTRUE_DSDS gradeClaim classification / basisPTEPEDFamily
99510432034-02-28DS/DP/U U-3507YNTRUE_DS
| B1C03 issued-claim review2026-10-15: TRUE_DS
———
99510432034-02-28ORANGE_BOOK U-3507YNTRUE_DS
English description not available.
———
100719852037-08-17DS/DP —YNTRUE_DS
| B1C03 issued-claim review2026-10-15: TRUE_DS
———
100719852037-08-17ORANGE_BOOK —YNTRUE_DS
English description not available.
———
106548272037-08-17U U-3507NYU
| B1C03 issued-claim review2026-10-15: U
———
106548272037-08-17ORANGE_BOOK U-3507NYU
English description not available.
———
112677992038-08-16DS —NNDP
| B1C03 issued-claim review2026-10-15: DP
———
112677992038-08-16ORANGE_BOOK —NNDP
English description not available.
———
125942672039-07-15DP —NNDP
| B1C03 issued-claim review2026-10-15: DP
———
125942672039-07-15ORANGE_BOOK —NNDP
English description not available.
———
119446112041-08-28U U-3507NNU
| B1C03 issued-claim review2026-10-15: U
———
119446112041-08-28ORANGE_BOOK U-3507NNU
English description not available.
———

Regulatory exclusivity

CodeStart dateEnd dateScopeEntire productAll indicationsFull coverage dateCombinationSource
NCE2022-12-222027-12-22English description not available.YY2027-12-22—Source
NCE2022-12-222027-12-22English description not available.YY2027-12-22
NCE
Full coverage date: 2027-12-22
Source

2026-10-10 · CURRENT_SOURCE_RECORDS_FOUND · Historical coverage: NOT_COMPLETE

Generic approval evidence

Application / productEventFinal dateTentative dateApplicantAuthorized genericExact mappingSource
No generic approval facts are linked to this product.

Market Entry Information

API filings, authorized generics and linked regulatory milestones.

API Master Files & Certifications 0 records

Ingredient-level registrations from linked public manufacturer portfolios. A filing does not establish supply to this finished product. DMFs are not FDA approvals.

APIHolder / manufacturerHolder countryFiling typeNumberStatusFiled dateAvailable for referenceSourceLast verified
No master-file or certification records are linked through public manufacturer portfolios.

Authorized Generics 0 records

Authorized generics are shown separately from independent ANDA approvals.

Application / productApplicantEvent / status First marketed Product mappingSourceLast verified
No authorized-generic records are linked to this product.

Tentative ANDA Approvals 0 records

Tentative approval is not final approval. Historical tentative approvals remain visible after a linked final approval.

Application / productApplicantEvent / status Tentative date Follow-up final approvalProduct mappingSourceLast verified
No tentative-approval records are linked to this product.

Paragraph IV Challenges 0 records

Paragraph IV challenges below are sourced from legal records separately from FDA approvals. An ANDA filing, lawsuit or settlement does not establish final approval or commercial launch.

Application / productApplicantEvent / status Certification event date Product mappingSourceLast verified
No structured Paragraph IV certification events are linked in the available approval evidence.

Final ANDA Approvals 0 records

Approval dates do not establish commercial launch. Product mapping is shown for each linked record.

Application / productApplicantEvent / status Final approval date Product mappingSourceLast verified
No final-approval records are linked to this product.
Decision evidence (8)
TypeDateRoleBasisSource
PATENT2034-02-28HISTORICAL_CONTEXTEnglish description not available.Source
PATENT2037-08-17CANONICAL_ANCHOREnglish description not available.Source
PATENT2037-08-17CANONICAL_ANCHOREnglish description not available.Source
PATENT2038-08-16FTO_TAILEnglish description not available.Source
PATENT2039-07-15NOT_APPLICABLE_TO_EXACT_PRODUCTEnglish description not available.Source
PATENT2041-08-28NOT_APPLICABLE_TO_EXACT_PRODUCTEnglish description not available.Source
REGULATORY_EXCLUSIVITY—REGULATORY_SCOPE_CONTEXTEnglish description not available.Source
REGULATORY_STATUS2037-08-17CANONICAL_DECISIONANCHOR_WITH_TAIL; US:NDA:215973:001; exact Final ANDA not verified; not proof of generic absenceSource
Independent legal-event information

Litigation & Settlement History

Settlement launch rights generally apply only to the named parties and product scope. These records do not change GenericRadar patent/exclusivity anchors or current decisions.

No litigation or settlement record currently linked to this product.